Cumberland Pharmaceuticals , Nasdaq: CPIX
Sells specialty pharmaceuticals, including a new injectable treatment for pain/fever.
Industry: Health Care
First Day Return: -1.0%
CPIX
Sells specialty pharmaceuticals, including a new injectable treatment for pain/fever.
| IPO Data | |
|---|---|
| IPO Date | 08/10/2009 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $85 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Nashville, TN, United States |
| Founded | 1999 |
| Employees at IPO | 59 |
| Website www.cumberlandpharma.com | |
IPO News for Cumberland Pharmaceuticals
Cumberland Pharmaceuticals (CPIX) Performance
